Recently, a specific CS-binding protein (VAR2SCA) derived from the malaria parasite was used to identify oncofetal CS expression in many cancer types, which can be taken as a diagnostic marker, circulating tumor cell indicator, or drug target35,36. The gene discussed is CS; the disease is neoplasm.